Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)
October 10, 2024
Ashley Hallock, 35, describes the day she joined a clinical trial studying stem cells for bipolar disorder as the most important day of her life.
“For me, it was a godsend,” she said.
October 9, 2024
Improving clinical outcomes in stroke patients by closing a gap between successful re-opening of a blocked vessel through endovascular surgery and a reduction of disability is the focus of a $2.5 million grant awarded to UTHealth Houston researchers.
October 8, 2024
An intervention study to improve outcomes for cancer survivors and enhance primary care capacity, funded with a $4.8 million grant from the National Cancer Institute, will be implemented by UTHealth Houston researchers in partnership with eight Texas primary care community health centers that treat under- and uninsured patients.
October 7, 2024
UTHealth Houston is the first institution in Houston to administer an FDA-approved drug, Kisunla (donanemab-azbt), for the treatment of early symptomatic Alzheimer’s disease.
The recipient, 79-year-old Terrie Frankel, received the infusion last week.
October 1, 2024
UTHealth Houston School of Public Health will partner with the U.S. Department of Health and Human Services Office of the National Coordinator (ONC) to equip students with the knowledge and skills needed to pursue successful careers in public service, particularly in health and human services.
September 27, 2024
From the outside, there is nothing about successful, busy attorney Brenda Adimora that hints at a disease she has fought all of her life. She maintains an active practice as a labor and employment attorney and was chair of the board of trustees of the Houston Young Lawyers Foundation.
September 25, 2024
Since he could remember, Jesus Mata has always had a cough he could not seem to kick. He had no idea that his simple cough was a sign of a serious and life-altering illness.
September 24, 2024
The undergraduate program at Cizik School of Nursing at UTHealth Houston continues to outrank all others in Texas, according to U.S. News & World Report’s 2025 U.S. News Best Colleges publication, which was released on Tuesday.
September 23, 2024
Findings of a study on a novel and minimally invasive laser therapy for patients with drug-resistant epilepsy caused by periventricular nodular heterotopia (PNVH) have been published by UTHealth Houston researchers in American Neurological Association’s Annals of Neurology.
September 20, 2024
On Sept. 1, 2024, four dedicated community leaders joined the UTHealth Houston Development Board. Under the leadership of Maria Pappas, Development Board chair, the board champions the university’s mission to educate health science professionals, conduct innovative research, and model best practices in clinical care and public health. With more than 140 members, the board promotes awareness and philanthropic support for the university’s critical initiatives to advance well-being throughout the region and beyond.
Use the form below to perform a new search.